Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection.
about
Recent progress in West Nile virus diagnosis and vaccinationFlaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile diseasePersistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis casesDevelopment and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodiesWest Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United StatesClinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada.NS1 protein secretion during the acute phase of West Nile virus infectionB cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.Performance characteristics of an in-house assay system used to detect West Nile Virus (WNV)-specific immunoglobulin M during the 2001 WNV season in the United States.Epitope-Blocking Enzyme-Linked Immunosorbent Assays for the Detection of Serum Antibodies to West Nile Virus in Multiple Avian SpeciesWest Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral OntarioDetection of West Nile Virus (WNV)-Specific Immunoglobulin M in a Reference Laboratory Setting during the 2002 WNV Season in the United StatesDifferentiation of West Nile and St. Louis Encephalitis Virus Infections by Use of Noninfectious Virus-Like Particles with Reduced Cross-ReactivityWest Nile virus surveillance and diagnostics: A Canadian perspectiveGenetically delivered antibody protects against West Nile virusDetection of North American West Nile Virus in Animal Tissue by a Reverse Transcription-Nested Polymerase Chain Reaction AssayDefining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and miceCase definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortiumDetection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.West Nile virus infections projected from blood donor screening data, United States, 2003An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003Emerging viral infections of the central nervous system: part 1.Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico.Diagnosis and management of acute encephalitis: A practical approach.Development of a double antibody sandwich ELISA for West Nile virus detection using monoclonal antibodies against non-structural protein 1IgG1 is pathogenic in Leishmania mexicana infectionSecond international diagnostic accuracy study for the serological detection of West Nile virus infection.West nile virus: current perspectives.Reproductive performance in sows in relation to Japanese Encephalitis Virus seropositivity in an endemic area.Neuro-intensive care of patients with acute CNS infections.West Nile virus encephalitis in a Barbary macaque (Macaca sylvanus).Venezuelan equine encephalitis virus, southern Mexico.West Nile virus IgM and IgG antibodies three years post- infection.Hybridization and population structure of the Culex pipiens complex in the islands of Macaronesia.Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation.West Nile virus infection and diplopia: a case report and review of literatureDiagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studiesPersistence of detectable immunoglobulin M antibodies up to 8 years after infection with West Nile virus.
P2860
Q21284433-9678D6AD-6B8C-4A20-BDCD-F9AAA72B61CFQ24273313-5E83BC71-48A0-4352-8C72-9C696F995FC8Q24570064-9CACD87F-F06E-4D25-BD57-BEEE66C6E872Q24570065-002ACB9D-8D0A-451F-8997-E1350B26D44AQ24727663-4933209F-729D-4481-AA4D-633FC0AE886FQ27469785-E2A9F155-3E7D-441E-A104-457066354C7FQ27471071-FDEA15E4-9A16-423A-9892-14B8820918CEQ27472078-E7A10CED-4505-4CEC-A28C-5953A00BEDF8Q27472703-09721110-51E9-4768-ACAE-873FCF2B9286Q27473103-4C125662-5C34-40C8-8B31-2F8EB32BFE8FQ27473169-6366320D-A523-4ABA-AAB4-81AD2D79A73AQ27473363-9AD38F27-D24A-4B8C-A45E-A20D8CB3B470Q27473563-0B6B7F14-D6E0-4B2F-BACC-F70F8987755DQ27480964-BD07876B-F876-4A6D-8361-360CBCCF1EB9Q27481450-6DC3EE71-C2ED-49D4-8C83-2FE5D10BA6FDQ27481984-4324C0A7-A2AF-4FFD-A54D-39B010D35217Q27485481-8C03290D-DC61-4131-AD12-ABA515634871Q27487804-CD6C25B4-13B9-4265-B6E5-9FBC87C28D71Q27488750-0A245DFD-9676-465F-9140-8C42A1B16B9FQ28533795-0D723942-3969-4079-90C1-28FBBEBAA2DFQ30827379-D46F0EFB-5B84-4C05-B451-E992978C4432Q31041026-B153B3CE-AD96-401D-812A-5C2F3A31C0D8Q33850880-E2653DD7-C880-4D9E-8252-2E969704DE22Q33866041-B21899C5-61FF-4219-9A37-9FA9E517C635Q33905035-987E2C15-66E2-47BF-9212-C2C0D20A88D9Q34000824-92000355-D814-4D83-AE36-4C4B5C7C4562Q34323186-8904414D-C4E6-4DB1-B7B0-945EED3A285AQ34337676-B1FB31DF-CDDE-4AAF-9ABF-D12390C9C6BFQ34702511-177984B2-9288-443E-8B08-D8B8320ECEE1Q35036664-1608C4BF-1CB9-4661-A0C4-5E8C4FC5DD73Q35638740-259569D7-4293-4464-948F-CD8C2EBEB02EQ35729708-4343C87D-8265-4A9B-B36D-F28DD46E8ED6Q35880161-EC936EED-5566-4ED8-94E7-AD7D13A453ADQ35881066-D26C2583-9B27-44F9-9D5F-040338F78E7BQ36071951-F53C1713-53B0-43F0-860C-5F130DA05723Q36209308-19B91F4A-D537-41AF-84DC-699F3A23E747Q36240567-7AAA89E7-A6D0-4967-9093-0CA2737ADEBEQ36880733-0486AD80-4EFB-406C-BBAA-EEEA5CDDD63EQ37271674-C70CF613-0E0E-4800-ACC0-37D40D3D194CQ37287761-B0E5FB57-DFB3-4BA3-BC37-80D5EF6FBF17
P2860
Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Evaluation of immunoglobulin M ...... of West Nile Virus infection.
@en
type
label
Evaluation of immunoglobulin M ...... of West Nile Virus infection.
@en
prefLabel
Evaluation of immunoglobulin M ...... of West Nile Virus infection.
@en
P2093
P2860
P1476
Evaluation of immunoglobulin M ...... s of West Nile Virus infection
@en
P2093
P2860
P304
P407
P577
2000-06-01T00:00:00Z